Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 125496 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 159953 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 220246 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 226437 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 239920 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 250323 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 270383 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 310443 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 331112 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 388271 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 422137 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 465042 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 487816 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 1544524 | Peak area normalized | female | diabetic | no neuropathy |